NHS tags:

Ambulance (4)

Blood Service (4)

Cleaners (5)

Coventry Hospital (1)

Doctors (9)

Health (97)

Healthcare (6)

Hospital (40)

Hospitals (29)

Huddersfield SOS (1)

Medical (1)

Mental health (10)

MRSA (1)

NHS (213)

PFI (35)

Polyclinics (6)

Private clinics (1)

PUSH (11)

Sicko (1)

Trusts (10)

Whipps Cross (6)

Campaigns and comments:

Anti-capitalism (115)

Anti-fascist (69)

Anti-racism (82)

Anti-war (157)

Asylum (14)

Black and Asian (23)

Children (6)

CNWP (61)

Corporate crime (1)

Disability (13)

Education (286)

Election campaigns (56)

Environment (90)

Food (14)

Health and safety (4)

Housing (59)

Human Rights (36)

LGBT Pride (13)

Local government (152)

Local services (77)

Low pay (31)

Nationalisation (24)

New workers party (105)

NHS (274)

Pensions (44)

Post Office (32)

Poverty (56)

Privatisation (194)

Public Services (94)

Socialism (82)

Sport (12)

Students (128)

The state (68)

Transport (86)

Welfare rights (19)

Women (57)

Workplace and TU campaigns (696)

Youth (155)

16 July 2008 | Print this articlePrint this article

Polyclinic courts Branson

A NORTH London paper, Camden New Journal, reports that health chiefs at Camden Primary Care Trust (PCT) secretly 'courted' a private company, Branson's Virgin Healthcare, to run a supersize polyclinic at University College London Hospital.

The PCT supported a deal that would shut down four local practices in Bloomsbury, end plans to open a state-of-the-art maternity ward and transfer over 50,000 Camden patients onto the books of a profit-making company.

The paper comments: "It has long been feared the new polyclinics were developed with private operators in mind, but not until now has the scale of efforts to bring them in been known."

Although Virgin directors turned down this offer, these talks took place. As the Camden New Journal says, it shows that "private companies are being primed for major roles in running the borough's health services.

And with it has come concerns that those in charge of the new polyclinics will ultimately be answerable to shareholders rather than patients."